A meta-analysis of clinical trials looked at how the medication dexmedetomidine affects anxiety in 1,373 adult patients undergoing surgery. The study focused on patients in the perioperative period, which includes the time before, during, and immediately after a surgical procedure.
The researchers found that patients who received dexmedetomidine had lower overall anxiety scores compared to those who did not. This effect was most noticeable within the first 24 hours after surgery. The study also found that dexmedetomidine was linked to better sleep quality after surgery. However, the medication did not show a significant impact on anxiety levels during the surgery itself or between 24 and 72 hours after the procedure.
It is important to note that this was a meta-analysis, which combines data from multiple studies. While the results show a link between dexmedetomidine and lower anxiety, the data across different time windows was limited. There were no reported differences in pain or depression levels between the groups. Patients should talk to their surgical team to see if this medication is appropriate for their specific needs.
